What happened
Pangen Biotech disclosed a supply contract with Korea Disease Control and Prevention Agency National Institute of Health, worth US$1.78M, about 20.46% of its recent annual revenue, running through Dec 2028.
For context, this single contract equals about 20.46% of the company's most recent annual revenue.
| Counterparty | Korea Disease Control and Prevention Agency National Institute of Health |
|---|---|
| Contract value | US$1.78M |
| vs. recent revenue | 20.46% |
| Through | Dec 2028 (from Jun 2026) |
| Filed | 2026-06-22, Supply contract signed |
| Source | DART rcept 20260622900231 → open original filing |
Source: DART. Information only, not investment advice.